Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kiovig prophylaxis against infections in high-grade glioma
2007-005548-25Phase 2Terminated
- Sponsor
- Regensburg University Medical Center
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in glioma comparing Kiovig + chemotherapy with Placebo + chemotherapy (2 arms). Primary endpoint: Number of infective episodes. Started Nov 2007; status: terminated.
02
Drugs
kiovig
03
Conditions
glioma
Beyond the preview
Go deeper on 2007-005548-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005548-25.